of 1 Next >
Results Found: 8
  • NYU Dataset

    SARS-CoV-2 Vaccine Breakthrough Infections in the NYU Langone Health System

    Authors
    Ralf Duerr
    Dacia Dimartino
    Christian Marier
    Paul Zappile
    5 more author(s)...
    Description

    This dataset contains a list of accession numbers of SARS-CoV-2 genomes obtained from 76 patients at NYU Langone Health who were fully vaccinated with the BNT162b2 (Pfizer/BioNTech), mRNA-1273 (Moderna), or JNJ-78436735 (Janssen) COVID-19 mRNA vaccines but had breakthrough infections between February 1 and April 30, 2021. 37 were male and 39 were female; the median age of patients was 48 years. There...

    Subject
    COVID-19
    Genomics
    Infectious Disease
    Timeframe
    2021
    Access Rights
    Free to All
    Application Required
  • NYU Dataset

    Novel Coronavirus Illness Patient Report Dataset

    Alternate Title(s)
    NCIPR
    Authors
    Moriah E. Thomason
    Denise Werchan
    Cassandra L. Hendrix
    Description

    The Novel Coronavirus Illness Patient Report (NCIPR) dataset includes survey responses from 2,212 confirmed COVID-19 patients aged 18 to 98 who were treated at NYU Langone Health facilities between February 2020 and March 2021 and consented to the survey. Survey invitations were distributed two waves: once in February 2021 and once in March 2021. Between waves, 9 new items were added to the survey...

    Subject
    COVID-19
    Infectious Disease
    Mental Health
    Population Characteristics
    Risk Factors
    Timeframe
    2021
    Access Rights
    Free to All
  • NYU Dataset

    Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York

    Authors
    Ralf Duerr
    Dacia Dimartino
    Christian Marier
    Paul Zappile
    10 more author(s)...
    Description

    Investigators obtained high quality SARS-CoV-2 sequences from 132 vaccinated and 283 unvaccinated individuals who were seen at NYU Langone Health facilities between May 1, 2021 and August 3, 2021. Fully vaccinated individuals received either two doses of the BNT162b2 (Pfizer/BioNTech) or mRNA-1273 (Moderna) vaccines, or a single-dose of the COVID-19 Janssen vaccine. Breakthrough infections were defined...

    Subject
    COVID-19
    Genomics
    Infectious Disease
    Timeframe
    2021
    Access Rights
    Free to All
    Application Required
  • NYU Dataset

    Immune Responses Observed Before and After BNT162b2 mRNA Vaccine Administration in Individuals with and without History of SARS-CoV-2 Infection

    Authors
    Marie I. Samanovic
    Amber R. Cornelius
    Sophie L. Gray-Gaillard
    Joseph Richard Allen
    7 more author(s)...
    Description

    To study and compare longitudinal immune responses to two-dose BNT162b2 mRNA vaccinations, investigators recruited 15 adults with a history of laboratory-confirmed COVID-19 and 21 adults who did not have COVID-19. Participants' ages ranged from 21 to 65 years old. Peripheral immune responses were assessed via blood samples drawn before and after each vaccine dose. A total of five samples were collected...

    Subject
    COVID-19
    Infectious Disease
    Timeframe
    2021
    Access Rights
    Free to All
  • NYU Dataset

    New York City COVID-19 Community Health Resources and Needs Assessment

    Alternate Title(s)
    NYC COVID-19 CHRNA
    Authors
    Lan Doan
    Laura Wyatt
    Simona Kwon
    Stella Yi
    Description

    The NYC COVID-19 Community Health Resources and Needs Assessment (CHRNA) survey was a collaboration between the NYU Center for the Study of Asian American Health, the Coalition for Asian American Children and Families, the Chinese-American Planning Council, and 28 community partners. The COVID-19 CHRNA survey was developed to understand the impact of the COVID-19 pandemic on the Asian American, Hispanic,...

    Subject
    COVID-19
    Health Status
    Infectious Disease
    Population Characteristics
    Timeframe
    2021
    Access Rights
    Free to All
    Application Required
  • NYU Dataset

    mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection

    Authors
    Ellie Ivanova
    Jasmine Shwetar
    Joseph C. Devlin
    Terkild B. Buus
    17 more author(s)...
    Description

    To investigate immune responses to SARS-CoV-2 antigens under various inflammatory conditions, researchers collected blood samples from five adult patients seen at NYU Langone Health with lab-confirmed cases of acute COVID-19 and from nine healthy adults (seven who had received the BNT162b2 mRNA vaccine and two with no prior exposure to SARS-CoV-2). Samples were obtained at multiple time points. Patients...

    Subject
    COVID-19
    Genomics
    Infectious Disease
    Access Rights
    Free to All
  • NYU Dataset

    Emergence and dissemination of SARS-CoV-2 XBB.1.5 in New York

    Authors
    Fabiana Gámbaro
    Ralf Duerr
    Dacia Dimartino
    Christian Marier
    4 more author(s)...
    Description

    This study compared SARS-CoV-2 sequences that were collected from infected patients (n=2,397) who were seen at NYU Langone Health facilities and globally (n=24,060 sequences in GISAID) between August 1, 2022, and February 4, 2023 to understand the proliferation of Omicron strain XBB.1.5. Active SARS-CoV-2 infection was confirmed with positive real-time (RT)-qPCR testing. To assess the association between...

    Subject
    COVID-19
    Genomics
    Infectious Disease
    Access Rights
    Free to All
  • NYU Dataset

    Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination

    Alternate Title(s)
    Vaccine‐generated Immunity in Ocrelizumab‐treated Patients: Longitudinal Assessments (VIOLA)
    Authors
    Ilya Kister
    Ryan Curtin
    Amanda L. Piquet
    Tyler Borko
    16 more author(s)...
    Description

    This is a prospective, two-year study of immunity against SARS-CoV-2 in multiple sclerosis patients receiving ocrelizumab (OCR) at the time of COVID vaccination. Researchers recruited 60 patients (aged 18-65) from the NYU MS Comprehensive Care Center in New York City and the Rocky Mountain MS Center at the University of Colorado Anschutz Medical Center in Aurora, CO. Participants provided blood samples...

    Subject
    Chronic Disease
    COVID-19
    Infectious Disease
    Access Rights
    Free to All